Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose and classify, but is also highly resistant to treatment. Available forms of therapy for this disease have not shown significant effects and patients rapidly develop resistance early on in therapy. These factors lead to the very poor prognosis observed with CMML patients, with median survival duration between 12 and 24 months after diagnosis. This study is therefore centered around evaluating the selective efficacy of a natural extract from dandelion roots, in inducing programmed cell death in aggressive and resistant CMML cell lines. models of CMML.The results from this study indicate that natural products, in particular Dandelion Root Extrac...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
Human chronic myelogenous leukemia (CML) is a malignancy of pluripotent hematopoietic cells characte...
Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose ...
BACKGROUND: Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard ...
Chronic Myelomonocytic Leukemia (CMML) is a form of cancer that arises due to a mutation in the bloo...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Recent statistics show a growing mortality rate from cancer with an estimate of 80,000 deaths in Can...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Ethnomedicinal knowledge of plant-derived bioactives could help us in discovering new therapeutic co...
The incidence of cancer worldwide is continuously on the rise, and the death toll associated with ca...
Purpose: To investigate the mechanisms of cytotoxicity of a dandelion extract against human gastric ...
The anti-leukemia activity of the saponin rich Gleditsia sinensis Lam. fruit extract (GSE) was inves...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
Human chronic myelogenous leukemia (CML) is a malignancy of pluripotent hematopoietic cells characte...
Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose ...
BACKGROUND: Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard ...
Chronic Myelomonocytic Leukemia (CMML) is a form of cancer that arises due to a mutation in the bloo...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Recent statistics show a growing mortality rate from cancer with an estimate of 80,000 deaths in Can...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and ...
Ethnomedicinal knowledge of plant-derived bioactives could help us in discovering new therapeutic co...
The incidence of cancer worldwide is continuously on the rise, and the death toll associated with ca...
Purpose: To investigate the mechanisms of cytotoxicity of a dandelion extract against human gastric ...
The anti-leukemia activity of the saponin rich Gleditsia sinensis Lam. fruit extract (GSE) was inves...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
International audienceUse of plant extracts, alone or combined to the current chemotherapy as chemos...
Human chronic myelogenous leukemia (CML) is a malignancy of pluripotent hematopoietic cells characte...